(c) 2024 PillSync.com

levothyroxine 300 mcg

1 INDICATIONS AND USAGE Hypothyroidism Levothyroxine sodium tablets are indicated in adult and pediatric patients, including neonates, as a replacement therapy in primary (thyroidal), secondary (pituitary), and tertiary (hypothalamic) congenital or acquired hypothyroidism. Pituitary Thyrotropin (Thyroid-Stimulating Hormone, TSH) Suppression Levothyroxine sodium tablets are indicated in adult and pediatric patients, including neonates, as an adjunct to surgery and radioiodine therapy in the management of thyrotropin-dependent well-differentiated thyroid cancer. Limitations of Use Levothyroxine sodium tablets are not indicated for suppression of benign thyroid nodules and nontoxic diffuse goiter in iodine-sufficient patients as there are no clinical benefits and overtreatment with levothyroxine sodium tablets may induce hyperthyroidism [see Warnings and Precautions (5.1) ] . Levothyroxine sodium tablets are not indicated for treatment of hypothyroidism during the recovery phase of subacute thyroiditis. Levothyroxine sodium is a L-thyroxine (T4) indicated in adult and pediatric patients, including neonates, for: Hypothyroidism: As replacement therapy in primary (thyroidal), secondary (pituitary), and tertiary (hypothalamic) congenital or acquired hypothyroidism. ( 1 ) Pituitary Thyrotropin (Thyroid-Stimulating Hormone, TSH) Suppression: As an adjunct to surgery and radioiodine therapy in the management of thyrotropin-dependent well-differentiated thyroid cancer. ( 1 ) Limitations of Use: not indicated for suppression of benign thyroid nodules and nontoxic diffuse goiter in iodine-sufficient patients Not indicated for treatment of hypothyroidism during the recovery phase of subacute thyroiditis

aurobindo pharma limited


3 months ago ROUND GREEN LV 300 levothyroxine 300 mcg

ROUND GREEN LV 300

16 HOW SUPPLIED/STORAGE AND HANDLING How Supplied

LEVOTHYROXINE SODIUM Tablets, USP are supplied as follows:

LEVOTHYROXINE SODIUM Tablets, USP 137 mcg are round, biconvex, turquoise color, mottled tablet, debossed with “137” and partial bisect (functional) on one side and “LV” on the other side and are available as follows: Bottles of 90 NDC 59651-554-90 Bottles of 1,000 NDC 59651-554-99

LEVOTHYROXINE SODIUM Tablets, USP 150 mcg are round, biconvex, blue color, mottled tablet, debossed with “150” and partial bisect (functional) on one side and “LV” on the other side and are available as follows: Bottles of 90 NDC 59651-555-90 Bottles of 1,000 NDC 59651-555-99

LEVOTHYROXINE SODIUM Tablets, USP 175 mcg are round, biconvex, lilac color, mottled tablet, debossed with “175” and partial bisect (functional) on one side and “LV” on the other side and are available as follows: Bottles of 90 NDC 59651-556-90 Bottles of 1,000 NDC 59651-556-99

LEVOTHYROXINE SODIUM Tablets, USP 200 mcg are round, biconvex, pink color, mottled tablet, debossed with “200” and partial bisect (functional) on one side and “LV” on the other side and are available as follows: Bottles of 90 NDC 59651-557-90 Bottles of 1,000 NDC 59651-557-99

LEVOTHYROXINE SODIUM Tablets, USP 300 mcg are round, biconvex, green color, mottled tablet, debossed with “300” and partial bisect (functional) on one side and “LV” on the other side and are available as follows: Bottles of 90 NDC 59651-558-90 Bottles of 1,000 NDC 59651-558-99 Storage and Handling Store

LEVOTHYROXINE SODIUM tablets, USP at 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to 86°F) [See USP Controlled Room Temperature].

LEVOTHYROXINE SODIUM tablets, USP should be protected from light and moisture.


More pills like ROUND LV 300

Related Pills

levothyroxine 200 mcg

aurobindo pharma limited

levothyroxine 175 mcg

aurobindo pharma limited

levothyroxine 150 mcg

aurobindo pharma limited

levothyroxine 137 mcg

aurobindo pharma limited

gabapentin 300 mg Gralise

Assertio Therapeutics, Inc.

gabapentin 300 mg Gralise

Assertio Therapeutics, Inc.












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site